Selected research
Market Outlook & Growth Opportunities
Global Pharmaceutical and Medical Device Testing Market Outlook and Growth Opportunities 2026
Market perspective
The global Pharmaceutical and Medical Device Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Pharmaceutical and Medical Device Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pharmaceutical and Medical Device Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pharmaceutical and Medical Device Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Pharmaceutical and Medical Device Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Pharmaceutical and Medical Device Testing market include SGS, Shimadzu, Charles River Laboratories, Eurofins, RCTS, Nelson Laboratories, DeviceLab, EAG Laboratories and EdgeOne Medical, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Pharmaceutical and Medical Device Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pharmaceutical and Medical Device Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pharmaceutical and Medical Device Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmaceutical and Medical Device Testing market.
Pharmaceutical and Medical Device Testing Segment by Company
SGS
Shimadzu
Charles River Laboratories
Eurofins
RCTS
Nelson Laboratories
DeviceLab
EAG Laboratories
EdgeOne Medical
Element
NAMSA
Pace Labs
Intertek
Associates of Cape Cod (ACC)
Tentamus
EKG Labs
MycoScience
GDMDT
Guangdong Lewwin
GTTC
PONY
Guangzhou Guobiao
CAS Testing Technical Services
Guangzhou General Pharmaceutical Research Institute
Guangdong Huawei Testing
Shanghai Ingeer
CIRS
Shanghai Fuda
Pharmaceutical and Medical Device Testing Segment by Type
Drug Testing
Medical Device Testing
Pharmaceutical and Medical Device Testing Segment by Application
Enterprise
Research Institution
College and University
Pharmaceutical and Medical Device Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Pharmaceutical and Medical Device Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Pharmaceutical and Medical Device Testing key companies, revenue, market share, and recent developments.
3. To split the Pharmaceutical and Medical Device Testing breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Pharmaceutical and Medical Device Testing market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Pharmaceutical and Medical Device Testing significant trends, drivers, influence factors in global and regions.
6. To analyze Pharmaceutical and Medical Device Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical and Medical Device Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical and Medical Device Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical and Medical Device Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical and Medical Device Testing industry.
Chapter 3: Detailed analysis of Pharmaceutical and Medical Device Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Pharmaceutical and Medical Device Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Pharmaceutical and Medical Device Testing in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Pharmaceutical and Medical Device Testing Industry Trends
Table 2. Pharmaceutical and Medical Device Testing Industry Drivers
Table 3. Pharmaceutical and Medical Device Testing Industry Opportunities and Challenges
Table 4. Pharmaceutical and Medical Device Testing Industry Restraints
Table 5. Global Pharmaceutical and Medical Device Testing Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Pharmaceutical and Medical Device Testing Revenue Share by Company (2021-2026)
Table 7. Global Pharmaceutical and Medical Device Testing Company Ranking, (2024-2026) & (US$ Million)
Table 8. Global Pharmaceutical and Medical Device Testing Key Company Manufacturing Base & Headquarters
Table 9. Global Pharmaceutical and Medical Device Testing Company, Product Type & Application
Table 10. Global Pharmaceutical and Medical Device Testing Company Establishment Date
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Pharmaceutical and Medical Device Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Significant Companies of Drug Testing
Table 15. Significant Companies of Medical Device Testing
Table 16. Global Pharmaceutical and Medical Device Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 17. Global Pharmaceutical and Medical Device Testing Sales Value by Type (2021-2026) & (US$ Million)
Table 18. Global Pharmaceutical and Medical Device Testing Sales Value by Type (2027-2032) & (US$ Million)
Table 19. Global Pharmaceutical and Medical Device Testing Sales Value Share by Type (2021-2026)
Table 20. Global Pharmaceutical and Medical Device Testing Sales Value Share by Type (2027-2032)
Table 21. Significant Companies of Enterprise
Table 22. Significant Companies of Research Institution
Table 23. Significant Companies of College and University
Table 24. Global Pharmaceutical and Medical Device Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 25. Global Pharmaceutical and Medical Device Testing Sales Value by Application (2021-2026) & (US$ Million)
Table 26. Global Pharmaceutical and Medical Device Testing Sales Value by Application (2027-2032) & (US$ Million)
Table 27. Global Pharmaceutical and Medical Device Testing Sales Value Share by Application (2021-2026)
Table 28. Global Pharmaceutical and Medical Device Testing Sales Value Share by Application (2027-2032)
Table 29. Global Pharmaceutical and Medical Device Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 30. Global Pharmaceutical and Medical Device Testing Sales Value by Region (2021-2026) & (US$ Million)
Table 31. Global Pharmaceutical and Medical Device Testing Sales Value Share by Region (2021-2026)
Table 32. Global Pharmaceutical and Medical Device Testing Sales Value by Region (2027-2032) & (US$ Million)
Table 33. Global Pharmaceutical and Medical Device Testing Sales Value Share by Region (2027-2032)
Table 34. Global Pharmaceutical and Medical Device Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 35. Global Pharmaceutical and Medical Device Testing Sales Value by Country (2021-2026) & (US$ Million)
Table 36. Global Pharmaceutical and Medical Device Testing Sales Value Market Share by Country (2021-2026)
Table 37. Global Pharmaceutical and Medical Device Testing Sales Value by Country (2027-2032) & (US$ Million)
Table 38. Global Pharmaceutical and Medical Device Testing Sales Value Market Share by Country (2027-2032)
Table 39. SGS Company Information
Table 40. SGS Business Overview
Table 41. SGS Pharmaceutical and Medical Device Testing Revenue (US$ Million) and Gross Margin (2021-2026)
Table 42. SGS Pharmaceutical and Medical Device Testing Product Portfolio
Table 43. SGS Recent Development
Table 44. Shimadzu Company Information
Table 45. Shimadzu Business Overview
Table 46. Shimadzu Pharmaceutical and Medical Device Testing Revenue (US$ Million) and Gross Margin (2021-2026)
Table 47. Shimadzu Pharmaceutical and Medical Device Testing Product Portfolio
Table 48. Shimadzu Recent Development
Table 49. Charles River Laboratories Company Information
Table 50. Charles River Laboratories Business Overview
Table 51. Charles River Laboratories Pharmaceutical and Medical Device Testing Revenue (US$ Million) and Gross Margin (2021-2026)
Table 52. Charles River Laboratories Pharmaceutical and Medical Device Testing Product Portfolio
Table 53. Charles River Laboratories Recent Development
Table 54. Eurofins Company Information
Table 55. Eurofins Business Overview
Table 56. Eurofins Pharmaceutical and Medical Device Testing Revenue (US$ Million) and Gross Margin (2021-2026)
Table 57. Eurofins Pharmaceutical and Medical Device Testing Product Portfolio
Table 58. Eurofins Recent Development
Table 59. RCTS Company Information
Table 60. RCTS Business Overview
Table 61. RCTS Pharmaceutical and Medical Device Testing Revenue (US$ Million) and Gross Margin (2021-2026)
Table 62. RCTS Pharmaceutical and Medical Device Testing Product Portfolio
Table 63. RCTS Recent Development
Table 64. Nelson Laboratories Company Information
Table 65. Nelson Laboratories Business Overview
Table 66. Nelson Laboratories Pharmaceutical and Medical Device Testing Revenue (US$ Million) and Gross Margin (2021-2026)
Table 67. Nelson Laboratories Pharmaceutical and Medical Device Testing Product Portfolio
Table 68. Nelson Laboratories Recent Development
Table 69. DeviceLab Company Information
Table 70. DeviceLab Business Overview
Table 71. DeviceLab Pharmaceutical and Medical Device Testing Revenue (US$ Million) and Gross Margin (2021-2026)
Table 72. DeviceLab Pharmaceutical and Medical Device Testing Product Portfolio
Table 73. DeviceLab Recent Development
Table 74. EAG Laboratories Company Information
Table 75. EAG Laboratories Business Overview
Table 76. EAG Laboratories Pharmaceutical and Medical Device Testing Revenue (US$ Million) and Gross Margin (2021-2026)
Table 77. EAG Laboratories Pharmaceutical and Medical Device Testing Product Portfolio
Table 78. EAG Laboratories Recent Development
Table 79. EdgeOne Medical Company Information
Table 80. EdgeOne Medical Business Overview
Table 81. EdgeOne Medical Pharmaceutical and Medical Device Testing Revenue (US$ Million) and Gross Margin (2021-2026)
Table 82. EdgeOne Medical Pharmaceutical and Medical Device Testing Product Portfolio
Table 83. EdgeOne Medical Recent Development
Table 84. Element Company Information
Table 85. Element Business Overview
Table 86. Element Pharmaceutical and Medical Device Testing Revenue (US$ Million) and Gross Margin (2021-2026)
Table 87. Element Pharmaceutical and Medical Device Testing Product Portfolio
Table 88. Element Recent Development
Table 89. NAMSA Company Information
Table 90. NAMSA Business Overview
Table 91. NAMSA Pharmaceutical and Medical Device Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 92. NAMSA Pharmaceutical and Medical Device Testing Product Portfolio
Table 93. NAMSA Recent Development
Table 94. Pace Labs Company Information
Table 95. Pace Labs Business Overview
Table 96. Pace Labs Pharmaceutical and Medical Device Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 97. Pace Labs Pharmaceutical and Medical Device Testing Product Portfolio
Table 98. Pace Labs Recent Development
Table 99. Intertek Company Information
Table 100. Intertek Business Overview
Table 101. Intertek Pharmaceutical and Medical Device Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 102. Intertek Pharmaceutical and Medical Device Testing Product Portfolio
Table 103. Intertek Recent Development
Table 104. Associates of Cape Cod (ACC) Company Information
Table 105. Associates of Cape Cod (ACC) Business Overview
Table 106. Associates of Cape Cod (ACC) Pharmaceutical and Medical Device Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 107. Associates of Cape Cod (ACC) Pharmaceutical and Medical Device Testing Product Portfolio
Table 108. Associates of Cape Cod (ACC) Recent Development
Table 109. Tentamus Company Information
Table 110. Tentamus Business Overview
Table 111. Tentamus Pharmaceutical and Medical Device Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 112. Tentamus Pharmaceutical and Medical Device Testing Product Portfolio
Table 113. Tentamus Recent Development
Table 114. EKG Labs Company Information
Table 115. EKG Labs Business Overview
Table 116. EKG Labs Pharmaceutical and Medical Device Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 117. EKG Labs Pharmaceutical and Medical Device Testing Product Portfolio
Table 118. EKG Labs Recent Development
Table 119. MycoScience Company Information
Table 120. MycoScience Business Overview
Table 121. MycoScience Pharmaceutical and Medical Device Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 122. MycoScience Pharmaceutical and Medical Device Testing Product Portfolio
Table 123. MycoScience Recent Development
Table 124. GDMDT Company Information
Table 125. GDMDT Business Overview
Table 126. GDMDT Pharmaceutical and Medical Device Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 127. GDMDT Pharmaceutical and Medical Device Testing Product Portfolio
Table 128. GDMDT Recent Development
Table 129. Guangdong Lewwin Company Information
Table 130. Guangdong Lewwin Business Overview
Table 131. Guangdong Lewwin Pharmaceutical and Medical Device Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 132. Guangdong Lewwin Pharmaceutical and Medical Device Testing Product Portfolio
Table 133. Guangdong Lewwin Recent Development
Table 134. GTTC Company Information
Table 135. GTTC Business Overview
Table 136. GTTC Pharmaceutical and Medical Device Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 137. GTTC Pharmaceutical and Medical Device Testing Product Portfolio
Table 138. GTTC Recent Development
Table 139. PONY Company Information
Table 140. PONY Business Overview
Table 141. PONY Pharmaceutical and Medical Device Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 142. PONY Pharmaceutical and Medical Device Testing Product Portfolio
Table 143. PONY Recent Development
Table 144. Guangzhou Guobiao Company Information
Table 145. Guangzhou Guobiao Business Overview
Table 146. Guangzhou Guobiao Pharmaceutical and Medical Device Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 147. Guangzhou Guobiao Pharmaceutical and Medical Device Testing Product Portfolio
Table 148. Guangzhou Guobiao Recent Development
Table 149. CAS Testing Technical Services Company Information
Table 150. CAS Testing Technical Services Business Overview
Table 151. CAS Testing Technical Services Pharmaceutical and Medical Device Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 152. CAS Testing Technical Services Pharmaceutical and Medical Device Testing Product Portfolio
Table 153. CAS Testing Technical Services Recent Development
Table 154. Guangzhou General Pharmaceutical Research Institute Company Information
Table 155. Guangzhou General Pharmaceutical Research Institute Business Overview
Table 156. Guangzhou General Pharmaceutical Research Institute Pharmaceutical and Medical Device Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 157. Guangzhou General Pharmaceutical Research Institute Pharmaceutical and Medical Device Testing Product Portfolio
Table 158. Guangzhou General Pharmaceutical Research Institute Recent Development
Table 159. Guangdong Huawei Testing Company Information
Table 160. Guangdong Huawei Testing Business Overview
Table 161. Guangdong Huawei Testing Pharmaceutical and Medical Device Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 162. Guangdong Huawei Testing Pharmaceutical and Medical Device Testing Product Portfolio
Table 163. Guangdong Huawei Testing Recent Development
Table 164. Shanghai Ingeer Company Information
Table 165. Shanghai Ingeer Business Overview
Table 166. Shanghai Ingeer Pharmaceutical and Medical Device Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 167. Shanghai Ingeer Pharmaceutical and Medical Device Testing Product Portfolio
Table 168. Shanghai Ingeer Recent Development
Table 169. CIRS Company Information
Table 170. CIRS Business Overview
Table 171. CIRS Pharmaceutical and Medical Device Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 172. CIRS Pharmaceutical and Medical Device Testing Product Portfolio
Table 173. CIRS Recent Development
Table 174. Shanghai Fuda Company Information
Table 175. Shanghai Fuda Business Overview
Table 176. Shanghai Fuda Pharmaceutical and Medical Device Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 177. Shanghai Fuda Pharmaceutical and Medical Device Testing Product Portfolio
Table 178. Shanghai Fuda Recent Development
Table 179. Research Programs/Design for This Report
Table 180. Authors List of This Report
Table 181. Secondary Sources
Table 182. Primary Sources
List of Figures
Figure 1. Pharmaceutical and Medical Device Testing Product Image
Figure 2. Global Pharmaceutical and Medical Device Testing Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Pharmaceutical and Medical Device Testing Market Size (2021-2032) & (US$ Million)
Figure 4. Global Pharmaceutical and Medical Device Testing Company Revenue Ranking in 2025 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 7. Drug Testing Image
Figure 8. Medical Device Testing Image
Figure 9. Global Pharmaceutical and Medical Device Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 10. Global Pharmaceutical and Medical Device Testing Sales Value Share 2021 VS 2025 VS 2032
Figure 11. Global Pharmaceutical and Medical Device Testing Sales Value Share by Type (2021-2032)
Figure 12. Enterprise Image
Figure 13. Research Institution Image
Figure 14. College and University Image
Figure 15. Global Pharmaceutical and Medical Device Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 16. Global Pharmaceutical and Medical Device Testing Sales Value Share 2021 VS 2025 VS 2032
Figure 17. Global Pharmaceutical and Medical Device Testing Sales Value Share by Application (2021-2032)
Figure 18. Global Pharmaceutical and Medical Device Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 19. Global Pharmaceutical and Medical Device Testing Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 20. North America Pharmaceutical and Medical Device Testing Sales Value (2021-2032) & (US$ Million)
Figure 21. North America Pharmaceutical and Medical Device Testing Sales Value Share by Country (%), 2025 VS 2032
Figure 22. Europe Pharmaceutical and Medical Device Testing Sales Value (2021-2032) & (US$ Million)
Figure 23. Europe Pharmaceutical and Medical Device Testing Sales Value Share by Country (%), 2025 VS 2032
Figure 24. Asia-Pacific Pharmaceutical and Medical Device Testing Sales Value (2021-2032) & (US$ Million)
Figure 25. Asia-Pacific Pharmaceutical and Medical Device Testing Sales Value Share by Country (%), 2025 VS 2032
Figure 26. South America Pharmaceutical and Medical Device Testing Sales Value (2021-2032) & (US$ Million)
Figure 27. South America Pharmaceutical and Medical Device Testing Sales Value Share by Country (%), 2025 VS 2032
Figure 28. Middle East & Africa Pharmaceutical and Medical Device Testing Sales Value (2021-2032) & (US$ Million)
Figure 29. Middle East & Africa Pharmaceutical and Medical Device Testing Sales Value Share by Country (%), 2025 VS 2032
Figure 30. USA Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 31. USA Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 32. USA Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 33. Canada Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 34. Canada Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 35. Canada Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 36. Mexico Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 37. Mexico Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 38. Mexico Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 39. Germany Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 40. Germany Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 41. Germany Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 42. France Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 43. France Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 44. France Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 45. U.K. Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 46. U.K. Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 47. U.K. Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 48. Italy Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 49. Italy Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 50. Italy Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 51. Spain Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 52. Spain Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 53. Spain Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 54. Russia Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 55. Russia Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 56. Russia Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 57. Netherlands Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 58. Netherlands Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 59. Netherlands Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 60. Nordic Countries Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 61. Nordic Countries Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 62. Nordic Countries Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 63. China Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 64. China Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 65. China Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 66. Japan Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 67. Japan Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 68. Japan Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 69. South Korea Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 70. South Korea Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 71. South Korea Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 72. India Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 73. India Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 74. India Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 75. Australia Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 76. Australia Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 77. Australia Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 78. Southeast Asia Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 79. Southeast Asia Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 80. Southeast Asia Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 81. Brazil Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 82. Brazil Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 83. Brazil Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 84. Argentina Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 85. Argentina Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 86. Argentina Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 87. Chile Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 88. Chile Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 89. Chile Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 90. Colombia Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 91. Colombia Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 92. Colombia Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 93. Peru Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 94. Peru Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 95. Peru Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 96. Saudi Arabia Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 97. Saudi Arabia Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 98. Saudi Arabia Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 99. Israel Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 100. Israel Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 101. Israel Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 102. UAE Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 103. UAE Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 104. UAE Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 105. Turkey Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 106. Turkey Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 107. Turkey Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 108. Iran Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 109. Iran Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 110. Iran Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 111. Egypt Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 112. Egypt Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 113. Egypt Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 114. Years Considered
Figure 115. Research Process
Figure 116. Key Executives Interviewed
Scope & coverage.
Types
- Drug Testing
- Medical Device Testing
Applications
- Enterprise
- Research Institution
- College and University
Companies covered
- SGS
- Shimadzu
- Charles River Laboratories
- Eurofins
- RCTS
- Nelson Laboratories
- DeviceLab
- EAG Laboratories
- EdgeOne Medical
- Element
- NAMSA
- Pace Labs
- Intertek
- Associates of Cape Cod (ACC)
- Tentamus
- EKG Labs
- MycoScience
- GDMDT
- Guangdong Lewwin
- GTTC
- PONY
- Guangzhou Guobiao
- CAS Testing Technical Services
- Guangzhou General Pharmaceutical Research Institute
- Guangdong Huawei Testing
- Shanghai Ingeer
- CIRS
- Shanghai Fuda
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Pharmaceutical and Medical Device Testing Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Pharmaceutical and Medical Device Testing Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Pharmaceutical and Medical Device Testing Market Dynamics
- 2.1 Pharmaceutical and Medical Device Testing Industry Trends
- 2.2 Pharmaceutical and Medical Device Testing Industry Drivers
- 2.3 Pharmaceutical and Medical Device Testing Industry Opportunities and Challenges
- 2.4 Pharmaceutical and Medical Device Testing Industry Restraints
3 Pharmaceutical and Medical Device Testing Market by Company
- 3.1 Global Pharmaceutical and Medical Device Testing Company Revenue Ranking in 2025
- 3.2 Global Pharmaceutical and Medical Device Testing Revenue by Company (2021-2026)
- 3.3 Global Pharmaceutical and Medical Device Testing Company Ranking (2024-2026)
- 3.4 Global Pharmaceutical and Medical Device Testing Company Manufacturing Base and Headquarters
- 3.5 Global Pharmaceutical and Medical Device Testing Company Product Type and Application
- 3.6 Global Pharmaceutical and Medical Device Testing Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Pharmaceutical and Medical Device Testing Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Pharmaceutical and Medical Device Testing Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Pharmaceutical and Medical Device Testing Market by Type
- 4.1 Pharmaceutical and Medical Device Testing Type Introduction
- 4.1.1 Drug Testing
- 4.1.2 Medical Device Testing
- 4.2 Global Pharmaceutical and Medical Device Testing Sales Value by Type
- 4.2.1 Global Pharmaceutical and Medical Device Testing Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Pharmaceutical and Medical Device Testing Sales Value by Type (2021-2032)
- 4.2.3 Global Pharmaceutical and Medical Device Testing Sales Value Share by Type (2021-2032)
5 Pharmaceutical and Medical Device Testing Market by Application
- 5.1 Pharmaceutical and Medical Device Testing Application Introduction
- 5.1.1 Enterprise
- 5.1.2 Research Institution
- 5.1.3 College and University
- 5.2 Global Pharmaceutical and Medical Device Testing Sales Value by Application
- 5.2.1 Global Pharmaceutical and Medical Device Testing Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Pharmaceutical and Medical Device Testing Sales Value by Application (2021-2032)
- 5.2.3 Global Pharmaceutical and Medical Device Testing Sales Value Share by Application (2021-2032)
6 Pharmaceutical and Medical Device Testing Regional Value Analysis
- 6.1 Global Pharmaceutical and Medical Device Testing Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pharmaceutical and Medical Device Testing Sales Value by Region (2021-2032)
- 6.2.1 Global Pharmaceutical and Medical Device Testing Sales Value by Region: 2021-2026
- 6.2.2 Global Pharmaceutical and Medical Device Testing Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Pharmaceutical and Medical Device Testing Sales Value (2021-2032)
- 6.3.2 North America Pharmaceutical and Medical Device Testing Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Pharmaceutical and Medical Device Testing Sales Value (2021-2032)
- 6.4.2 Europe Pharmaceutical and Medical Device Testing Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Pharmaceutical and Medical Device Testing Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Pharmaceutical and Medical Device Testing Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Pharmaceutical and Medical Device Testing Sales Value (2021-2032)
- 6.6.2 South America Pharmaceutical and Medical Device Testing Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Pharmaceutical and Medical Device Testing Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Pharmaceutical and Medical Device Testing Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical and Medical Device Testing Country-level Value Analysis
- 7.1 Global Pharmaceutical and Medical Device Testing Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Pharmaceutical and Medical Device Testing Sales Value by Country (2021-2032)
- 7.2.1 Global Pharmaceutical and Medical Device Testing Sales Value by Country (2021-2026)
- 7.2.2 Global Pharmaceutical and Medical Device Testing Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.7.2 France Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.14.2 China Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.17.2 India Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Pharmaceutical and Medical Device Testing Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Pharmaceutical and Medical Device Testing Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Pharmaceutical and Medical Device Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 SGS
- 8.1.1 SGS Company Information
- 8.1.2 SGS Business Overview
- 8.1.3 SGS Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.1.4 SGS Pharmaceutical and Medical Device Testing Product Portfolio
- 8.1.5 SGS Recent Developments
- 8.2 Shimadzu
- 8.2.1 Shimadzu Company Information
- 8.2.2 Shimadzu Business Overview
- 8.2.3 Shimadzu Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.2.4 Shimadzu Pharmaceutical and Medical Device Testing Product Portfolio
- 8.2.5 Shimadzu Recent Developments
- 8.3 Charles River Laboratories
- 8.3.1 Charles River Laboratories Company Information
- 8.3.2 Charles River Laboratories Business Overview
- 8.3.3 Charles River Laboratories Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.3.4 Charles River Laboratories Pharmaceutical and Medical Device Testing Product Portfolio
- 8.3.5 Charles River Laboratories Recent Developments
- 8.4 Eurofins
- 8.4.1 Eurofins Company Information
- 8.4.2 Eurofins Business Overview
- 8.4.3 Eurofins Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.4.4 Eurofins Pharmaceutical and Medical Device Testing Product Portfolio
- 8.4.5 Eurofins Recent Developments
- 8.5 RCTS
- 8.5.1 RCTS Company Information
- 8.5.2 RCTS Business Overview
- 8.5.3 RCTS Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.5.4 RCTS Pharmaceutical and Medical Device Testing Product Portfolio
- 8.5.5 RCTS Recent Developments
- 8.6 Nelson Laboratories
- 8.6.1 Nelson Laboratories Company Information
- 8.6.2 Nelson Laboratories Business Overview
- 8.6.3 Nelson Laboratories Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.6.4 Nelson Laboratories Pharmaceutical and Medical Device Testing Product Portfolio
- 8.6.5 Nelson Laboratories Recent Developments
- 8.7 DeviceLab
- 8.7.1 DeviceLab Company Information
- 8.7.2 DeviceLab Business Overview
- 8.7.3 DeviceLab Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.7.4 DeviceLab Pharmaceutical and Medical Device Testing Product Portfolio
- 8.7.5 DeviceLab Recent Developments
- 8.8 EAG Laboratories
- 8.8.1 EAG Laboratories Company Information
- 8.8.2 EAG Laboratories Business Overview
- 8.8.3 EAG Laboratories Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.8.4 EAG Laboratories Pharmaceutical and Medical Device Testing Product Portfolio
- 8.8.5 EAG Laboratories Recent Developments
- 8.9 EdgeOne Medical
- 8.9.1 EdgeOne Medical Company Information
- 8.9.2 EdgeOne Medical Business Overview
- 8.9.3 EdgeOne Medical Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.9.4 EdgeOne Medical Pharmaceutical and Medical Device Testing Product Portfolio
- 8.9.5 EdgeOne Medical Recent Developments
- 8.10 Element
- 8.10.1 Element Company Information
- 8.10.2 Element Business Overview
- 8.10.3 Element Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.10.4 Element Pharmaceutical and Medical Device Testing Product Portfolio
- 8.10.5 Element Recent Developments
- 8.11 NAMSA
- 8.11.1 NAMSA Company Information
- 8.11.2 NAMSA Business Overview
- 8.11.3 NAMSA Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.11.4 NAMSA Pharmaceutical and Medical Device Testing Product Portfolio
- 8.11.5 NAMSA Recent Developments
- 8.12 Pace Labs
- 8.12.1 Pace Labs Company Information
- 8.12.2 Pace Labs Business Overview
- 8.12.3 Pace Labs Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.12.4 Pace Labs Pharmaceutical and Medical Device Testing Product Portfolio
- 8.12.5 Pace Labs Recent Developments
- 8.13 Intertek
- 8.13.1 Intertek Company Information
- 8.13.2 Intertek Business Overview
- 8.13.3 Intertek Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.13.4 Intertek Pharmaceutical and Medical Device Testing Product Portfolio
- 8.13.5 Intertek Recent Developments
- 8.14 Associates of Cape Cod (ACC)
- 8.14.1 Associates of Cape Cod (ACC) Company Information
- 8.14.2 Associates of Cape Cod (ACC) Business Overview
- 8.14.3 Associates of Cape Cod (ACC) Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.14.4 Associates of Cape Cod (ACC) Pharmaceutical and Medical Device Testing Product Portfolio
- 8.14.5 Associates of Cape Cod (ACC) Recent Developments
- 8.15 Tentamus
- 8.15.1 Tentamus Company Information
- 8.15.2 Tentamus Business Overview
- 8.15.3 Tentamus Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.15.4 Tentamus Pharmaceutical and Medical Device Testing Product Portfolio
- 8.15.5 Tentamus Recent Developments
- 8.16 EKG Labs
- 8.16.1 EKG Labs Company Information
- 8.16.2 EKG Labs Business Overview
- 8.16.3 EKG Labs Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.16.4 EKG Labs Pharmaceutical and Medical Device Testing Product Portfolio
- 8.16.5 EKG Labs Recent Developments
- 8.17 MycoScience
- 8.17.1 MycoScience Company Information
- 8.17.2 MycoScience Business Overview
- 8.17.3 MycoScience Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.17.4 MycoScience Pharmaceutical and Medical Device Testing Product Portfolio
- 8.17.5 MycoScience Recent Developments
- 8.18 GDMDT
- 8.18.1 GDMDT Company Information
- 8.18.2 GDMDT Business Overview
- 8.18.3 GDMDT Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.18.4 GDMDT Pharmaceutical and Medical Device Testing Product Portfolio
- 8.18.5 GDMDT Recent Developments
- 8.19 Guangdong Lewwin
- 8.19.1 Guangdong Lewwin Company Information
- 8.19.2 Guangdong Lewwin Business Overview
- 8.19.3 Guangdong Lewwin Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.19.4 Guangdong Lewwin Pharmaceutical and Medical Device Testing Product Portfolio
- 8.19.5 Guangdong Lewwin Recent Developments
- 8.20 GTTC
- 8.20.1 GTTC Company Information
- 8.20.2 GTTC Business Overview
- 8.20.3 GTTC Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.20.4 GTTC Pharmaceutical and Medical Device Testing Product Portfolio
- 8.20.5 GTTC Recent Developments
- 8.21 PONY
- 8.21.1 PONY Company Information
- 8.21.2 PONY Business Overview
- 8.21.3 PONY Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.21.4 PONY Pharmaceutical and Medical Device Testing Product Portfolio
- 8.21.5 PONY Recent Developments
- 8.22 Guangzhou Guobiao
- 8.22.1 Guangzhou Guobiao Company Information
- 8.22.2 Guangzhou Guobiao Business Overview
- 8.22.3 Guangzhou Guobiao Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.22.4 Guangzhou Guobiao Pharmaceutical and Medical Device Testing Product Portfolio
- 8.22.5 Guangzhou Guobiao Recent Developments
- 8.23 CAS Testing Technical Services
- 8.23.1 CAS Testing Technical Services Company Information
- 8.23.2 CAS Testing Technical Services Business Overview
- 8.23.3 CAS Testing Technical Services Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.23.4 CAS Testing Technical Services Pharmaceutical and Medical Device Testing Product Portfolio
- 8.23.5 CAS Testing Technical Services Recent Developments
- 8.24 Guangzhou General Pharmaceutical Research Institute
- 8.24.1 Guangzhou General Pharmaceutical Research Institute Company Information
- 8.24.2 Guangzhou General Pharmaceutical Research Institute Business Overview
- 8.24.3 Guangzhou General Pharmaceutical Research Institute Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.24.4 Guangzhou General Pharmaceutical Research Institute Pharmaceutical and Medical Device Testing Product Portfolio
- 8.24.5 Guangzhou General Pharmaceutical Research Institute Recent Developments
- 8.25 Guangdong Huawei Testing
- 8.25.1 Guangdong Huawei Testing Company Information
- 8.25.2 Guangdong Huawei Testing Business Overview
- 8.25.3 Guangdong Huawei Testing Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.25.4 Guangdong Huawei Testing Pharmaceutical and Medical Device Testing Product Portfolio
- 8.25.5 Guangdong Huawei Testing Recent Developments
- 8.26 Shanghai Ingeer
- 8.26.1 Shanghai Ingeer Company Information
- 8.26.2 Shanghai Ingeer Business Overview
- 8.26.3 Shanghai Ingeer Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.26.4 Shanghai Ingeer Pharmaceutical and Medical Device Testing Product Portfolio
- 8.26.5 Shanghai Ingeer Recent Developments
- 8.27 CIRS
- 8.27.1 CIRS Company Information
- 8.27.2 CIRS Business Overview
- 8.27.3 CIRS Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.27.4 CIRS Pharmaceutical and Medical Device Testing Product Portfolio
- 8.27.5 CIRS Recent Developments
- 8.28 Shanghai Fuda
- 8.28.1 Shanghai Fuda Company Information
- 8.28.2 Shanghai Fuda Business Overview
- 8.28.3 Shanghai Fuda Pharmaceutical and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 8.28.4 Shanghai Fuda Pharmaceutical and Medical Device Testing Product Portfolio
- 8.28.5 Shanghai Fuda Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst